Compounds > candesartan cilexetil

candesartan cilexetil and angiotensinogen

candesartan cilexetil has been researched along with angiotensinogen in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, K; Matsui, T; Nagamatsu, T; Okamoto, H; Suzuki, Y; Takano, M; Yayama, K1
Fujisawa, Y; Inada, Y; Ishimura, Y; Kanagawa, R; Nishikawa, K; Ojima, M; Sanada, T; Shibouta, Y; Wada, T1
Nakamura, A; Niimi, R; Yanagawa, Y1
Carlson, T; Kowala, MC; Leadley, R; Major, TC; Okerberg, C; Olszewski, B; Ostroski, R; Rosebury, W; Schroeder, R1
Fu, H; Hosomi, N; Itano, T; Kohno, M; Liu, G; Masugata, H; Matsumoto, M; Miki, T; Nakano, D; Nishiyama, A; Pelisch, N; Sueda, Y; Ueno, M1

Other Studies

5 other study(ies) available for candesartan cilexetil and angiotensinogen

ArticleYear
Activation of the renin-angiotensin system in anti-glomerular basement membrane antibody-induced glomerulonephritis.
    Biological & pharmaceutical bulletin, 1995, Volume: 18, Issue:3

    Topics: Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Antibodies; Basement Membrane; Benzimidazoles; Biphenyl Compounds; Glomerular Mesangium; Glomerulonephritis; Liver; Male; Nephrotic Syndrome; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles

1995
Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1997, Volume: 19, Issue:7

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Cerebrovascular Disorders; Enalapril; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Renin; RNA, Messenger; Tetrazoles

1997
Suppression of endotoxin-induced renal tumor necrosis factor-alpha and interleukin-6 mRNA by renin-angiotensin system inhibitors.
    Japanese journal of pharmacology, 2002, Volume: 88, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Cytokines; Enalapril; Endotoxins; Gene Expression Regulation; Interleukin-6; Kidney; Lipopolysaccharides; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Tumor Necrosis Factor-alpha

2002
A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
    Cardiovascular drugs and therapy, 2008, Volume: 22, Issue:6

    Topics: Administration, Oral; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiotonic Agents; Drug Administration Schedule; Enalapril; Female; Glomerular Filtration Rate; Humans; Hypertrophy, Left Ventricular; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Structure; Piperidines; Quinolines; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Ultrasonography

2008
Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
    Journal of hypertension, 2011, Volume: 29, Issue:11

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain; Brain Edema; Brain Ischemia; Hypotension; Ischemia; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors

2011